MedTrace Logo

Undiagnosed Sleep Apnea and Bypass OperaTion

NCT02701504 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2020-03-26

No results posted yet for this study

Summary

Sleep apnea is a prevalent disorder in patients with coronary artery disease. Previous studies suggested sleep apnea was associated with coronary plaque burden and future adverse cardiovascular events after percutaneous coronary intervention. In the SABOT study, the investigators used a FDA-approved portable sleep device to diagnose sleep apnea, and evaluate the relationship between sleep apnea and cardiovascular outcomes after non-urgent coronary artery bypass surgery.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Chi-Hang Lee, MD · National University of Singapore

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-10-01
Primary Completion
2019-03-31
Completion
2019-03-31

Countries

  • Singapore

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02701504 on ClinicalTrials.gov